PRLD
Prelude Therapeutics Inc
+0.11 (+2.46%)4.58USD270K成交股數365M市值–本益比(近四季)16.3股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 5.7M | 4.6M | 5.6M+88% | 6.5M | 0.00 | 0.00 | 3.0M | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 16.1M | 13.6M | 18.0M | 21.7M | 25.8M | 28.8M | 29.5M | 29.5M | 27.4M | 30.3M | 26.3M | 25.0M |
| 銷售管理費用 | 5.0M | 5.2M | 5.0M | 5.2M | 6.4M | 5.8M | 7.9M | 7.7M | 6.9M | 7.0M | 7.1M | 7.4M |
| 營業利益 | −15.5M-52% | −14.2M-59% | −17.3M-50% | −20.4M-45% | −32.2M-6% | −34.6M-7% | −34.4M+3% | −37.2M+15% | −34.3M | −37.4M | −33.4M | −32.4M |
| 營業利益率 | -270.9% | -309.5% | -307.6% | -314.1% | – | – | -1,145.9% | – | – | – | – | – |
| 稅後淨利 | −13.9M-55% | −10.4M-68% | −16.5M-49% | −19.7M-43% | −31.2M-1% | −32.1M-3% | −32.3M+5% | −34.7M+14% | −31.4M | −33.1M | −30.6M | −30.4M |
| 淨利率 | -244.1% | -226.7% | -291.8% | -303.5% | – | – | -1,075.7% | – | – | – | – | – |
| 稀釋 EPS | -0.14-66% | -0.13-69% | -0.20-53% | -0.26-43% | -0.41-2% | -0.42-7% | -0.43-4% | -0.46-15% | -0.42 | -0.45 | -0.45 | -0.54 |
| 稀釋股數 | 98.4M | 82.5M | 77.0M | 76.1M | 76.0M | 76.0M | 75.9M | 75.8M | 75.7M | 60.4M | 67.6M | 56.2M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 26.3M | 21.8M | 35.3M | 47.5M | 25.8M | 40.3M | 11.1M | 27.8M | 24.7M | 25.3M | 15.9M | 26.4M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 189M | 120M | 141M | 94.8M | 115M | 141M | 197M | 224M | 247M | 278M | 259M | 281M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 55.6M | 59.5M | 72.7M | 36.2M | 39.1M | 38.1M | 40.8M | 42.0M | 36.4M | 40.6M | 20.3M | 18.6M |
| 股東權益 | 134M | 60.2M | 68.6M | 58.5M | 75.8M | 103M | 156M | 182M | 211M | 237M | 238M | 262M |
| 負債比 | 29.4% | 49.7% | 51.4% | 38.2% | 34.0% | 27.0% | 20.7% | 18.7% | 14.7% | 14.6% | 7.8% | 6.6% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −21.7M-37% | – | – | – | −34.2M | – | – | −31.8M | – | – | – |
| 資本支出 | – | 0.00 | – | – | – | 47K | – | – | 289K | – | – | – |
| 自由現金流 | – | −21.7M-37% | – | – | – | −34.3M | – | – | −32.1M | – | – | – |
| 折舊攤銷 | – | 391K | – | – | – | 435K | – | – | 426K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -473.5% | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 12.1M | +73.4% | −99.5M | -819.6% | -1.29 | −56.4M |
| FY2024 | 7.0M | – | −127M | -1,816.7% | -1.68 | −104M |
| FY2023 | – | – | −122M | –% | -2.02 | −111M |
| FY2022 | – | – | −115M | –% | -2.44 | −86.7M |
| FY2021 | – | – | −112M | –% | -2.43 | −85.9M |
| FY2020 | – | – | −56.9M | –% | -4.56 | −46.8M |
| FY2019 | – | – | −27.6M | –% | -16.52 | −26.4M |